Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence

NCT ID: NCT01948713

Last Updated: 2017-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

43 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-07

Study Completion Date

2015-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

INTRODUCTION: Stress urinary incontinence is a common condition in women and can be defined as the involuntary loss of urine on exertion, exercise, sneezing or coughing. This pathology causes physical discomfort and impacts the quality of life in a negative manner. Physiotherapeutic exercises is a treatment with low cost and high patient attendance. It can be applied with focus on strengthening the pelvic floor muscles or on muscular synergism. OBJECTIVE: To compare the effectiveness of Kegel exercises performed alone or performed in association with the strengthening of the muscles of the hip in the treatment of stress urinary incontinence. METHODOLOGY: The study is a randomized, blinded clinical trial. It aims at assessing objectively the strength of the pelvic floor, the improvement in the number of episodes of loss and impact on quality of life. The study will accept up to 40 women, who will be divided into two groups of physical therapy: group 1 (that will strengthen the pelvic floor muscles with Kegel exercises) and group 2 (that will perform strengthening the pelvic floor muscles with Kegel exercises associated with the strengthening of muscles of the hip). The two groups will be evaluated at the beginning and at the end of treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

the strength of the pelvic floor muscles will be evaluated with the aid of a perineometer

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Strengthening of pelvic floor muscles.

Group Type EXPERIMENTAL

Strengthening of pelvic floor muscles.

Intervention Type OTHER

Kegel exercises kinesiotherapy

Group 2

Strengthening of pelvic floor muscles associated with strengthening of hip muscles.

Group Type EXPERIMENTAL

Strengthening of pelvic floor muscles.

Intervention Type OTHER

Kegel exercises kinesiotherapy

Strengthening of hip muscles.

Intervention Type OTHER

Kegel exercises and strengthening of hip muscles as Gluteus Maximus and Medius and adductor muscles

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Strengthening of pelvic floor muscles.

Kegel exercises kinesiotherapy

Intervention Type OTHER

Strengthening of hip muscles.

Kegel exercises and strengthening of hip muscles as Gluteus Maximus and Medius and adductor muscles

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with 30 to 70 years of age;
* Clinical diagnosis of stress urinary incontinence;
* Urodynamic study.

Exclusion Criteria

* Stress urinary incontinence with sphincter deficiency;
* Urinary urgence;
* Mixed urinary incontinence;
* Pregnant women;
* Neurological or muscular disease that interfere with continence;
* Urinary infection;
* Genital prolapse;
* Gynecological surgery for urinary incontinence in the last year;
* Hormone replacement therapy;
* Strength 0 in functional evaluation of the pelvic floor muscles.
Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Simone A. Marques, researcher

Role: PRINCIPAL_INVESTIGATOR

University of Sao Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Sao Paulo General Hospital

São Paulo, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Hay-Smith EJC, Starzec-Proserpio M, Moller B, Aldabe D, Cacciari L, Pitangui ACR, Vesentini G, Woodley SJ, Dumoulin C, Frawley HC, Jorge CH, Morin M, Wallace SA, Weatherall M. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD009508. doi: 10.1002/14651858.CD009508.pub2.

Reference Type DERIVED
PMID: 39704322 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SimoneM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.